explore -WSS

explore

author：fashion 2025-10-01 00:47:33 - browse：7599

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA early review: GLP

WSS

Stories you might have missed in 2023: health, science, medicine

Apple Vision Pro: A first look at health apps on the new VR headset

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Vertigo drug brings hope for rare neuron disorder, Niemann

FDA early review: GLP

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

explore

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

What we need to know about Arena Bioworks

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Nonprofit, backed by Microsoft, to certify AI tools in health care

ChatGPT in medicine: STAT answers readers' burning questions

Nonprofit, backed by Microsoft, to certify AI tools in health care

Hepatitis C has a cure — but many Americans still lack access to it

Profiling embryos to choose those with higher IQs is almost a reality

Virginia high school admissions case could be legal follow

What we need to know about Arena Bioworks

leisure time

FDA drug safety: Singulair case shows systemic surveillance flaws

Medicare drug price negotiation’s day in court

Gene therapy denied for Afghan refugee whose father aided U.S.

Medicare Advantage overpayments discussion gets experts fired up

American taxpayers paid $1.8 trillion in health care costs in 2022

The real point of Kenneth Smith’s execution by nitrogen gas

Wikipedia

entertainment

hotspot

hotspot